Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 87
1991 214
1992 270
1993 224
1994 318
1995 248
1996 255
1997 303
1998 275
1999 409
2000 370
2001 380
2002 374
2003 349
2004 380
2005 534
2006 613
2007 609
2008 591
2009 668
2010 738
2011 740
2012 770
2013 647
2014 551
2015 551
2016 465
2017 567
2018 503
2019 384
2020 332
2021 177
Text availability
Article attribute
Article type
Publication date

Search Results

12,288 results
Results by year
Filters applied: . Clear all
Page 1
Identifying patients with NTRK fusion cancer.
Solomon JP, Benayed R, Hechtman JF, Ladanyi M. Solomon JP, et al. Ann Oncol. 2019 Nov 1;30(Suppl_8):viii16-viii22. doi: 10.1093/annonc/mdz384. Ann Oncol. 2019. PMID: 31738428 Free PMC article. Review.
The forefront of ovarian cancer therapy: update on PARP inhibitors.
Mirza MR, Coleman RL, González-Martín A, Moore KN, Colombo N, Ray-Coquard I, Pignata S. Mirza MR, et al. Ann Oncol. 2020 Sep;31(9):1148-1159. doi: 10.1016/j.annonc.2020.06.004. Epub 2020 Jun 20. Ann Oncol. 2020. PMID: 32569725 Review.
Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group.
Mosele F, Remon J, Mateo J, Westphalen CB, Barlesi F, Lolkema MP, Normanno N, Scarpa A, Robson M, Meric-Bernstam F, Wagle N, Stenzinger A, Bonastre J, Bayle A, Michiels S, Bièche I, Rouleau E, Jezdic S, Douillard JY, Reis-Filho JS, Dienstmann R, André F. Mosele F, et al. Ann Oncol. 2020 Nov;31(11):1491-1505. doi: 10.1016/j.annonc.2020.07.014. Epub 2020 Aug 24. Ann Oncol. 2020. PMID: 32853681 Review.
Efficacy of PI3K inhibitors in advanced breast cancer.
Verret B, Cortes J, Bachelot T, Andre F, Arnedos M. Verret B, et al. Ann Oncol. 2019 Dec 1;30(Suppl_10):x12-x20. doi: 10.1093/annonc/mdz381. Ann Oncol. 2019. PMID: 31859349 Free PMC article. Review.
Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting.
Amant F, Berveiller P, Boere IA, Cardonick E, Fruscio R, Fumagalli M, Halaska MJ, Hasenburg A, Johansson ALV, Lambertini M, Lok CAR, Maggen C, Morice P, Peccatori F, Poortmans P, Van Calsteren K, Vandenbroucke T, van Gerwen M, van den Heuvel-Eibrink M, Zagouri F, Zapardiel I. Amant F, et al. Ann Oncol. 2019 Oct 1;30(10):1601-1612. doi: 10.1093/annonc/mdz228. Ann Oncol. 2019. PMID: 31435648 Free article. Review.
Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019.
Burstein HJ, Curigliano G, Loibl S, Dubsky P, Gnant M, Poortmans P, Colleoni M, Denkert C, Piccart-Gebhart M, Regan M, Senn HJ, Winer EP, Thurlimann B; Members of the St. Gallen International Consensus Panel on the Primary Therapy of Early Breast Cancer 2019. Burstein HJ, et al. Ann Oncol. 2019 Oct 1;30(10):1541-1557. doi: 10.1093/annonc/mdz235. Ann Oncol. 2019. PMID: 31373601 Free article.
TRK inhibitors in TRK fusion-positive cancers.
Drilon A. Drilon A. Ann Oncol. 2019 Nov 1;30(Suppl_8):viii23-viii30. doi: 10.1093/annonc/mdz282. Ann Oncol. 2019. PMID: 31738426 Free PMC article. Review.
Identifying patients with NTRK fusion cancer.
Solomon JP, Benayed R, Hechtman JF, Ladanyi M. Solomon JP, et al. Ann Oncol. 2019 Nov;30 Suppl 8:viii16-viii22. doi: 10.1093/annonc/mdz384. Epub 2019 Dec 24. Ann Oncol. 2019. PMID: 32223934 Review.
12,288 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page